Showing results (1-10 of 122) with videos related to
Sort By:
Pageof 13
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 6, 1998
Evaluation of olopatadine, a new ophthalmic antiallergic agent with dual activity, using the conjunctival allergen challenge modelM B AbelsonExpert Opinion on Pharmacotherapy|August 28, 2004
A review of olopatadine for the treatment of ocular allergyMark B AbelsonCurrent Allergy and Asthma Reports|June 7, 2003
Conjunctival allergen challenge: models in the investigation of ocular allergyMark B Abelson, Oliver LoefflerEuropean Journal of Ophthalmology|April 1, 1994
Levocabastine eye drops: a new approach for the treatment of acute allergic conjunctivitisM B Abelson, D WeintraubClinical Therapeutics|July 11, 2003
A randomized, double-blind, parallel-group comparison of olopatadine 0.1% ophthalmic solution versus placebo for controlling the signs and symptoms of seasonal allergic conjunctivitis and rhinoconjunctivitisMark B Abelson, Darell TurnerClinical Therapeutics|December 12, 2003
Double-masked, randomized, placebo-controlled clinical study of the mast cell-stabilizing effects of treatment with olopatadine in the conjunctival allergen challenge model in humansAndrea Leonardi, Mark B AbelsonSurvey of Ophthalmology|July 1, 1993
Conjunctivitis of allergic origin: immunologic mechanisms and current approaches to therapyM B Abelson, K SchaeferThe Journal of the Florida Medical Association|April 1, 1994
Nonsteroidal anti-inflammatory drugs. Current ophthalmic therapyM B Abelson, J SloanCurrent Allergy and Asthma Reports|July 11, 2006
Ocular allergy in pediatric practiceMark B Abelson, David GranetAmerican Journal of Ophthalmology|June 30, 1998
Combined analysis of two studies using the conjunctival allergen challenge model to evaluate olopatadine hydrochloride, a new ophthalmic antiallergic agent with dual activityM B Abelson, L SpitalnyPageof 13